Table 1.
Baseline indicators of PCOS subjects and controls
| Controls (n = 60) | PCOS (n = 86) | P value | |
|---|---|---|---|
| Age* | 28.15 ± 2.69 | 28.43 ± 3.42 | 0.6 |
| BMI (kg/m2)* | 21.81 ± 3.09 | 23.91 ± 3.73 | 0.001 |
| Fasting glucose (mmol/L)* | 5.15 ± 0.5 | 5.4 ± 0.55 | 0.005 |
| Fasting insulin (mIU/L)# | 7.7 (6.14–9.61) | 12.69 (8.66–26.88) | <0.001& |
| HOMA-IR# | 1.75 (1.36-2.22) | 2.89 (1.79–5.34) | <0.001& |
| FSH (mIU/mL)* | 6.56 ± 1.2 | 5.93 ± 1.16 | 0.002 |
| LH (mIU/mL)* | 5.32 ± 1.67 | 6.99 ± 2.82 | <0.001 |
| LH/FSH# | 0.79 (0.63-1.01) | 1.06 (0.78–1.57) | <0.001& |
| E2 (pg/mL)# | 33.20 (26.08–43.48) | 34.90 (27.45–49.65) | 0.193& |
| T (ng/dL)* | 23.90 ± 8.05 | 33.82 ± 13.83 | <0.001 |
PCOS polycystic ovary syndrome, BMI body mass index, HOMA-IR homoeostasis model insulin resistance index, LH luteinizing hormone, FSH follicle-stimulating hormone, E2 estradiol, T total testosterone, SD standard deviation
*Values are presented as the mean ± SD for continuous indicators following normal distribution
#Values are presented as the median (interquartile range) for continuous indicators not following normal distribution
&t-test after variables obeying normal distribution through log transformation